Approval · Notice of Compliance 4289 · 1996
PHOSLO: Notice of Compliance 4289
Issued September 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4289
- Date
- September 19, 1996
- Company
- Braintree Laboratories Inc.Braintree, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Phosphate binder
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHOSLO | 02229437 | Cancelled Post Market |
Medicinal ingredients
- CALCIUM ACETATE 667 MG per TAB